Medicine & Life Sciences

1. Aromatase Inhibitors 15%
2. Bortezomib 15%
3. Breast Neoplasms 5%
4. Canada 53%
5. Cause of Death 10%
6. Cetuximab 15%
7. Clinical Trials 24%
8. Colorectal Neoplasms 5%
9. Confidence Intervals 5%
10. Cyclophosphamide 11%
11. Dexamethasone 11%
12. Drug Therapy 7%
13. Exanthema 6%
14. Factor VIII 31%
15. factor VIII, von Willebrand factor drug combination 18%
16. Follicular Lymphoma 15%
17. Hemophilia A 100%
18. Hemophilia B 6%
19. Hepacivirus 7%
20. HIV 14%
21. HIV Antibodies 6%
22. HIV-1 10%
23. human F8 protein 19%
24. imidazole 5%
25. Immune Tolerance 30%
26. Interferons 12%
27. Letrozole 13%
28. Life Expectancy 7%
29. Maintenance 11%
30. marimastat 22%
31. Melphalan 22%
32. Multiple Myeloma 24%
33. National Cancer Institute (U.S.) 43%
34. Observation 8%
35. Organizations 10%
36. Placebos 17%
37. Population 9%
38. Prednisone 31%
39. Progression-Free Survival 6%
40. Registries 24%
41. Rituximab 13%
42. Safety 9%
43. Small Cell Lung Carcinoma 14%
44. Survival 15%
45. Therapeutics 13%
46. Vincristine 13%
47. Virus Diseases 10%
48. von Willebrand Diseases 16%
49. von Willebrand Factor 13%